BU’s Dr. Toby C. Chai Elected Trustee of The American Board of Urology
Charlottesville (September 2022) Dr. Toby C. Chai, Chair of the Department of Urology at Boston University School of Medicine and Chief of Urology at Boston Medical Center in Boston, Massachusetts, has been elected Trustee of the American Board of Urology (ABU). His six-year term will begin on February 23, 2023. Dr. Chai was nominated to the ABU by the American Urological Association (AUA).
Founded in 1935, the American Board of Urology acts for the benefit of the public by establishing and maintaining standards of certification for urologists, working with certified urologists to achieve lifelong learning to insure the delivery of high quality, safe and ethical urologic care. Six urologic societies nominate to the ABU and sponsor its activities, including the American Urological Association, the American Association of Genitourinary Surgeons, the American Association of Clinical Urologists, the American College of Surgeons, the Society of Academic Urologists, and the Societies for Pediatric Urology.
Toby C. Chai received his B.A. degree from Johns Hopkins University and M.D. degree from Indiana University School of Medicine. He completed a urology residency at the University of Michigan Medical Center. Following residency, he did a post-doctoral research fellowship at the University of Virginia Health Sciences Center.
Dr. Chai was on faculty at the University of Maryland School of Medicine, rising to Professor with tenure and holder of the John D. Young endowed Professorship. He then moved to Yale University School of Medicine where he was Professor and Vice Chair of Research in the Department of Urology. In 2019, he assumed the position of Chair of Department of Urology at Boston University School of Medicine, Chief of Urology at Boston Medical Center, and President of Boston University Medical Center Urologists, Inc. Dr. Chai leads the urology service in an urban academic health center whose mission is to provide exceptional care without exception with a vision to make Boston the healthiest urban population in the world by 2030.
Dr. Chai’s has been actively involved in urologic research to seek improvements in urologic care. He received career development awards from the American Foundation for Urologic Diseases (AFUD) and a K08 grant from the National Institutes of Health (NIH) prior to receiving independently funded investigator-initiated research awards from the NIH as principal investigator including R01, U01 and P20 grant mechanisms. He has been recognized for his academic accomplishments including the Society of Basic Urologic Research (SBUR) Young Investigator Award; the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Zimskind Award and Distinguished Service Award; the American Urological Association (AUA) Victor A. Politano Award for outstanding work in treatment of urinary incontinence and innovations in bladder research and Distinguished Service Award for work on urologic research advocacy. He is a recipient of the Continence Champion award from the advocacy group, National Association for Continence.
Dr. Chai serves as an Associate Editor for Journal of Urology and on the Editorial Board for American Journal of Physiology – Renal Physiology. He has served as both a charter member and ad hoc member of numerous NIH grant review committees. He was a charter member for the US Food and Drug Administration (FDA) Bone, Reproductive, and Urologic Drug Advisory Committee.